MwanzoCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Bei iliyotangulia
$Â 8.50
Bei za siku
$Â 7.50 - $Â 8.17
Bei za mwaka
$Â 5.20 - $Â 22.20
Thamani ya kampuni katika soko
4.29M USD
Wastani wa hisa zilizouzwa
elfu 8.93
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 10.00 | -37.50% |
Matumizi ya uendeshaji wa biashara | 2.19M | -68.12% |
Mapato halisi | -1.96M | 67.56% |
Kiwango cha faida halisi | elfu -19.57 | 48.09% |
Mapato kwa kila hisa | -0.18 | 97.55% |
EBITDA | -2.18M | 68.18% |
Asilimia ya kodi ya mapato | 9.69% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.98M | -49.83% |
Jumla ya mali | 5.38M | -56.94% |
Jumla ya dhima | 6.35M | -22.55% |
Jumla ya hisa | elfu -970.00 | — |
hisa zilizosalia | 6.29M | — |
Uwiano wa bei na thamani | -18.89 | — |
Faida inayotokana na mali | -80.21% | — |
Faida inayotokana mtaji | -32,014.71% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -1.96M | 67.56% |
Pesa kutokana na shughuli | -3.07M | 24.01% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | elfu -1.00 | 98.00% |
Mabadiliko halisi ya pesa taslimu | -3.02M | 28.48% |
Mtiririko huru wa pesa | -2.31M | 8.20% |
Kuhusu
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Ilianzishwa
13 Ago 1996
Makao Makuu
Tovuti
Wafanyakazi
12
